🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The researchers are doing this study to provide access to treatment with 13...
Status
No Longer Available
Location
Memorial Sloan Kettering Cancer Center
Start Date
TBD
Trial ID
NCT05064306
Treatments Being Tested
Omburtamab is a murine IgG1 monoclonal antibody, recognizing CD276 (also kn...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03
Trial ID
NCT05063357
Treatments Being Tested
Children with a neuroblastoma diagnose and central nervous system (CNS)/lep...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2018-12-11
Trial ID
NCT03275402
Treatments Being Tested
A Phase 2 study investigating the addition of cRIT 131I-omburtamab to irino...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-04-04
Trial ID
NCT04743661
The purpose of this study is to test any good and bad effects of the study ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2019-07-15
Trial ID
NCT04022213
Treatments Being Tested
The purpose of this study is to test the feasibility and toxicity of admini...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2004-02-05
Trial ID
NCT00089245
Treatments Being Tested